Literature DB >> 6207124

Acting mechanisms of Lentinan in human--II. Enhancement of non-specific cell-mediated cytotoxicity as an interferon inducer.

H Miyakoshi, T Aoki, M Mizukoshi.   

Abstract

The immunopotentiator "Lentinan" augmented the cell-mediated cytotoxicity in humans. (a) The activation of killer T cells by the mixed lymphocyte culture was accelerated only when responder cells were mixed with both a suboptimum number of stimulator cells and Lentinan. (b) The interferon level in the peripheral blood circulation of cancer patients was elevated in 12 h following Lentinan administration, and natural killer activity of peripheral mononuclear cells was enhanced in 48 h. These data indicate that Lentinan favorably affects the host mechanisms of man.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6207124     DOI: 10.1016/0192-0561(84)90057-2

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  3 in total

1.  In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan.

Authors:  M Tani; H Tanimura; H Yamaue; M Iwahashi; T Tsunoda; M Tamai; K Noguchi; K Arii
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  The effects of beta-glucan on human immune and cancer cells.

Authors:  Godfrey Chi-Fung Chan; Wing Keung Chan; Daniel Man-Yuen Sze
Journal:  J Hematol Oncol       Date:  2009-06-10       Impact factor: 17.388

Review 3.  The use of lentinan for treating gastric cancer.

Authors:  Kenji Ina; Takae Kataoka; Takafumi Ando
Journal:  Anticancer Agents Med Chem       Date:  2013-06       Impact factor: 2.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.